Parameter | t (9;22) n = (4) | t(1;19) n = (8) | 11q23 rearrangement n = (4) |
---|---|---|---|
Age | |||
<1 year- | 0 | 4 | 2 |
1–9 years | 2 | 4 | 2 |
> 10 years | 2 | 0 | 0 |
Sex | |||
Male | 4 | 6 | 2 |
Female | 0 | 2 | 2 |
Clinical data | |||
Hepatomegaly | 4 | 8 | 2 |
Splenomegaly | 4 | 4 | 4 |
Lymphadenopathy | 4 | 8 | 0 |
CNS infiltration | 2 | 0 | 2 |
Laboratory data (at diagnosis) | Mean (± SD) | Mean (± SD) | Mean (± SD) |
TLC (× 109/L) | 86.1 ± 48.9 | 87.4 ± 44.81 | 89.25 ± 17.04 |
Hb (gm/dl) | 6.7 ± 1.1 | 7.93 ± 2.12 | 9.05 ± 1.63 |
Platelets(× 109/L) | 46.5 ± 7.7 | 49.75 ± 34.07 | 55.50 ± 13.44 |
Peripheral blood blasts (%) | 29.0 ± 4.2 | 28.0 ± 28.93 | 18.50 ± 3.54 |
Blasts in B.M (%) | 68.5 ± 3.5 | 58.5 ± 18.27 | 63.5 ± 38.89 |
Laboratory data (at day 15 of induction) | Mean (± SD) | Mean (± SD) | Mean (± SD) |
TLC (× 109/L) | 1.8 ± 1.4 | 1.25 ± 0.45 | 1.80 ± 1.41 |
Hb (gm/dl) | 7.7 ± 0.4 | 7.8 ± 1.14 | 7.85 ± 0.49 |
Platelets(× 109/L) | 110.5 ± 27.6 | 51.0 ± 29.46 | 69.5 ± 23.33 |
Blasts in B.M (%) | 12.5 ± 13.4 | 10.25 ± 7.5 | 13.50 ± 7.78 |
MRD status at day 15 | |||
Good outcome | 2 | 2 | 0 |
Bad outcome | 2 | 6 | 4 |